# DESCRIPTION

## FIELD OF THE INVENTION

- define novel antimicrobial compounds

## BACKGROUND OF THE INVENTION

- motivate need for novel antimicrobial compounds
- summarize limitations of current antimicrobial therapies

## SUMMARY OF THE INVENTION

- disclose guaA gene expression control
- present antibiotic-like compounds with antimicrobial activity
- describe compounds with specific structural formulas
- provide specific embodiments of compounds
- define compounds
- describe applications
- provide specific embodiments
- list compositions
- define composition for microbial infection treatment
- describe methods of preventing or treating microbial infections
- outline uses of non ribosylable ligand of guanine riboswitch
- describe methods of disinfecting and/or sterilizing an object
- outline uses of compound defined above or above-mentioned composition
- describe method of selecting a pathogen treatable by non ribosylable ligand
- describe method of identifying a compound for treating or preventing microbial infection
- describe method for preventing the development of multi-drug resistance of a bacteria
- describe composition and kit for preventing or treating microbial infections

## DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS

- describe gene guaA and its role in microbial pathogens
- describe discovery of guanine riboswitches and their control of guaA expression

### Definitions

- define terms used in specification and claims
- explain meaning of "comprising", "having", "including", and "containing"

### Oral

- describe formulations for oral administration

### Nasal

- describe formulations for nasal administration

### Transmucosal or Transdermal

- describe formulations for transmucosal or transdermal administration

### Parenteral

- describe formulations for parenteral administration

### Salts, Esters, Hydrates and Solvates

- define pharmacologically acceptable salts
- list examples of salts
- describe formation of salts
- define pharmacologically acceptable esters
- describe formation of esters
- define hydrates and solvates
- describe prodrugs and solvates

### Stereoisomers, Enantiomers, Racemates, Tautomers

- describe stereoisomers, enantiomers, racemates, and tautomers

### Dosages

- describe dosages of compounds

### Toxicity and Therapeutic Efficacy

- describe toxicity and therapeutic efficacy of compounds

## EXAMPLE 1

### guaA Expression in S. aureus Isolates from Infected Cows and from Milk

- identify genes expressed by S. aureus strains in vivo during bovine mastitis
- compare guaA expression in S. aureus isolates from infected cows and milk

## EXAMPLE 2

### Polycistronic RNA Encoding xpt/pbuX/guaB/guaA

- redefine operon xpt/pbuX/guaB/guaA structure in S. aureus

## EXAMPLE 3

### Ability of Compounds of the Invention to Bind Guanine Riboswitches

- demonstrate compounds' ability to bind guanine riboswitches

## EXAMPLE 4

### Growth Inhibition of Bacterial Species Possessing a Guanine Riboswitch that Controls the Expression of the guaA Gene by Compounds of the Present Invention

- describe growth inhibition of bacterial species

### EXAMPLE 5

- describe preclusion from ribosylation of compounds of the present invention

### EXAMPLE 6

- describe minimal inhibitory concentrations and bactericidal activities of compounds of the present invention

### EXAMPLE 7

- describe bactericidal activity of compound 1.01 on various S. aureus strains

### EXAMPLE 8

- describe mode of action of compounds of the present invention

### EXAMPLE 9

- describe inhibitory effect of compounds of the present invention during in vivo infection in mice and cows

### EXAMPLE 10

- describe prevention of rapid development of bacterial resistance in S. aureus

### EXAMPLE 11

- describe illustrative compounds of the present invention

### EXAMPLE 12

- describe effect of compounds of the present invention on the treatment of infections

### EXAMPLE 13

- describe aspects relating to synthesis of compounds of the present invention

### EXAMPLE 14

- describe bio-informatics search of guanine riboswitches

### EXAMPLE 15

- demonstrate antibiotic activity of compounds

### EXAMPLE 16

- synthesize compounds 7 and 8

